Showing results (161-170 of 172) with videos related to
Sort By:
Pageof 18
International Journal of Clinical Oncology|June 24, 2022
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxelShintaro Narita, Takahiro Kimura, Shingo Hatakeyama, et al.World Journal of Urology|February 26, 2022
Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapyShintaro Narita, Takahiro Kimura, Shingo Hatakeyama, et al.Journal of the American Society of Nephrology : JASN|December 4, 2012
Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritisAllison M Lesher, Lin Zhou, Yuko Kimura, et al.Scandinavian Journal of Gastroenterology|October 17, 2025
Undifferentiated histology is associated with missed gastric cancer in individuals with prior Helicobacter pylori eradication undergoing screening endoscopyKenta Watanabe, So Takahashi, Sho Fukuda, et al.Medical Oncology (Northwood, London, England)|March 13, 2021
Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in JapanYumina Muto, Shintaro Narita, Shingo Hatakeyama, et al.Blood|January 7, 2017
Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutationYoshiyasu Ueda, Imran Mohammed, Delu Song, et al.Journal of Gastroenterology|June 18, 2021
A simple prediction score for in-hospital mortality in patients with nonvariceal upper gastrointestinal bleedingTamotsu Matsuhashi, Waku Hatta, Takuto Hikichi, et al.The Prostate|September 30, 2024
Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapyShintaro Narita, Takafumi Yanagisawa, Shingo Hatakeyama, et al.Molecular Biology of the Cell|July 19, 2013
The Arf GAP SMAP2 is necessary for organized vesicle budding from the trans-Golgi network and subsequent acrosome formation in spermiogenesisTomo Funaki, Shunsuke Kon, Kenji Tanabe, et al.Journal of Cancer Research and Clinical Oncology|May 13, 2022
Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged ≥ 85 years: EGC-2 modelYosuke Toya, Tomohiro Shimada, Koichi Hamada, et al.Pageof 18